ECLINICAL TRIALS UPTAKE MEETS INDUSTRY RESISTANCE

According to a new report, the adoption of eClinical technologies has been hampered by the ability to take the electronic revolution to the next level, as the adoption of eClinical technologies currently remain confined to localised start-up projects. "In eClinical trials (eCT), it is the human element of resistance to change that is the greatest challenge rather than the technology itself," said Frost & Sullivan's research analyst Raghavendra Chitta.

LabTechnologist.com (http://www.labtechnologist.com/news/printNewsBis.asp?id=65996)